PCA
MRSN icon

Pallas Capital Advisors’s Mersana Therapeutics MRSN Stock Holding History

Pallas Capital Advisors’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$28.6K Buy
3,868
+87
+2% +$644 ﹤0.01% 840
2025
Q1 		$32.5K Buy
+3,781
New +$32.5K ﹤0.01% 737